Mount Sinai Hospital, founded in 1852, is one of the oldest and largest teaching hospitals in the United States. It is located in East Harlem in the New York City borough of Manhattan, on the eastern border of Central Park stretching along Madison and Fifth Avenues, between East 98th Street and East 103rd Street.

There are 1,141 beds in Mount Sinai Hospital.

During the past decade, Mount Sinai Hospital conducted 334 clinical trials. In the 10-year time frame, 334 clinical trials started and 152 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 160 clinical trials started and 108 clinical trials were completed. i.e. 67.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mount Sinai Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 75 trials, followed by "Children's Oncology Group" with 35 trials sponsored, "Icahn School of Medicine at Mount Sinai" with 32 trials sponsored, "Abbott Medical Devices" with 26 trials sponsored and "Alliance for Clinical Trials in Oncology" with 26 trials sponsored. Other sponsors include 308 different institutions and companies that sponsored additional 217 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Sinai Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 70 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 14 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 8 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 8 trials as a collaborator. Other collaborators include 290 different institutions and companies that were collaborators in the rest 214 trials.

According to Clinical.Site data, the most researched conditions in "Mount Sinai Hospital" are "Coronary Artery Disease" (15 trials), "Heart Failure" (14 trials), "Acute Myeloid Leukemia" (12 trials), "Atrial Fibrillation" (9 trials) and "HIV Infections" (9 trials). Many other conditions were trialed in "Mount Sinai Hospital" in a lesser frequency.

Most popular intervention types in "Mount Sinai Hospital" are "Drug" (266 trials), "Other" (146 trials), "Device" (122 trials), "Biological" (84 trials) and "Procedure" (81 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (62 trials), "Quality-of-Life Assessment" (42 trials), "Placebo" (40 trials), "Cyclophosphamide" (32 trials) and "Carboplatin" (31 trials). Other intervention names were less common.

The vast majority of trials in "Mount Sinai Hospital" are 452 trials for "All" genders, 38 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 245 active trials in "Mount Sinai Hospital". 2 are not yet recruiting, 121 are recruiting, 114 are Active, not recruiting, and 8 are Enrolling by invitation. In total, there were 177 completed trials in Mount Sinai Hospital, 7 suspended trials, and 38 terminated clinical trials to date.

Out of the total trials that were conducted in Mount Sinai Hospital, 38 "Phase 1" clinical trials were conducted, 139 "Phase 2" clinical trials and 150 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 114 trials that are defined as “Not Applicable".